Widely-Prescribed Diabetes Drug Linked To Heart Attack Risks

Widely-Prescribed Diabetes Drug Linked To Heart Attack Risks

A new analysis Monday reported the widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death.

More than 6 million people worldwide have taken the drug sold by London-based GlaxoSmithKline PLC since it came on the market eight years ago. Pooled results of dozens of studies revealed a 45 percent higher risk of heart attack, according to the analysis published online by the New England Journal of Medicine.

Popular in the Community

Close

HuffPost Shopping’s Best Finds

MORE IN LIFE